Nestec S.a.

Societe Des Produits Nestle S.a.

Beth Israel Deaconess Medical Center, Inc.

Frederic Destaillats

Bruce R Bistrian

Norbert Sprenger

Catherine Mace

Heiko Oertling

Jalil Benyacoub

Fabiola Dionisi

Carine Blanchard

Cristina Cruz-Hernandez

Julie Moulin

Francesca Giuffrida

Gregory Savioz

Peter Erdmann

Sagar Thakkar

Isabelle Masserey-Elmelegy

Manuel Oliveira

Rajat Mukherjee

Valerie Petit

Delphine Egli

Yassaman Shahkhalili Dulloo

Carlos Antonio De Castro

Carlos Antonio DeCastro

Amaury Patin

Paul Michel

Florence Blancher

Sean Christopher Austin

Viral Brahmbhatt

Clementine Thabuis

Elizabeth Forbes-blom

Thibault Escalier

Laurence Sandoz

Jean-Charles Martin

Grégory Savioz

Delphine Tissot-Favre

Mohamed Nabil Bosco

Kornel Nagy

Brian Craft

Tristan Bourdeau

Kornél Nagy

Sophie Nutten

Julie Céline Moulin

Valérie Petit

The invention relates to a computer program executable on a computer () for assisting the preparation of infant formula in an infant feeding container using an electronic scale () arranged in communication with the computer. The invention also relates to an electronic scale () for assisting the preparation of infant formula comprising a communication module () arranged to communicate with the computer () hosting the computer program.

System for assisting the personalized preparation of infant formula including a connected electronic scale

Synthetic nutritional formulations, particularly milk based compositions, for infants and children are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity

The invention concerns synthetic nutritional formulations, particularly milk based compositions, for infants and children. The compositions are especially adapted to the age of the child, younger or older than three months. The invention further relates to administration of these compositions for promoting the healthy establishment of cognitive function in infant boys and girls and in young boys and girls up to the age of thirty-six months.

Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function

The invention concerns synthetic nutritional formulations, particularly milk based compositions, for infants and children. The compositions are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Synthetic nutritional compositions for infants and young children up to the age of thirty-six months, particularly infant formulae and growing-up milks, vary according to gender and the age of the infant or young child. The compositions have been designed to ensure balanced growth and to prevent obesity in in-fancy and later in life.

Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children

The present invention relates to a nutritional composition, for infants and young children (about 12 to 36 months) in which the sum of the triacylglycerols (TAG) sn-1(3) palmitic acid (PA), myristic acid (MA) and stearic acid (SA) constitutes less than 13.0% of the TAG. The composition promotes absorption of fatty acids and calcium in the gut, improves gut comfort, decreases abdominal pain associated with hard stool formation, promotes regular bowel movements and reduces the incidence and severity of constipation in infants and young children (up to the age of about three years old). The composition also promotes bone mineralization, increasing bone strength and bone mineral density.

Lipid composition for use in infants and young children for promoting gut comfort and optimal fat and calcium absorption

The present invention concerns a highly selective process for the preparation of an ingredient comprising 1,3-Olein-2-palmitin (OPO), a triglyceride present in human breast milk. The present invention also relates to 1,3-Olein-2-palmitin (OPO) ingredient obtainable by the process.

Synthesis of 1,3-olein-2-palmitin (OPO)

This invention relates to an age-tailored nutritional composition system comprising an adaptive level of human milk oligosaccharides (HMOS) and a method for preparing said system. The age-tailored nutritional composition system comprises at least two nutritional compositions for infants of a certain age, which differ from each other in the amount of HMOs present therein. It is specifically adapted to the evolving nutritional needs of infants from their birth to the end of the breast feeding period.

Infant formula system with adaptive levels of human milk oligosaccharides (HMOs)

A packaging system for infant nutritional composition with dosing devices (), comprises a first dosing device () for dispensing a first quantity of said infant nutritional composition, said first quantity being adapted to boys, and a second dosing device () for dispensing a second quantity of said infant nutritional composition, said second quantity being adapted to girls, said first quantity being different from said second quantity.

Packaging system for infant nutritional composition with dosing devices

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising a sn-2 monoacylglycerol derivative, wherein the sn-1 and sn-3 positions are blocked by protective groups. The acyl group may be a fatty acid, for example one with anti-inflammatory properties.

Sn-2-monoacylglycerols and lipid malabsorption

The invention concerns a synthetic infant formula composition with a low content of medium-chain fatty acids in specific proportions and a relatively high content of unsaturated fatty acids, preferably polyunsaturated fatty acids. This composition is for infants, preferably preterm infants. This composition has been designed to promote the healthy establishment of cognitive function.

Infant formula with a low content of MCFAS in specific proportions and a relatively high content of unsaturated fatty acids, and its use in promoting the healthy establishment of cognitive function in infants

Sn-2-monoacylgycerols and lipid malabsorption

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising sn-1(3) monoacylglycerols, wherein the sn-1 or sn-3 position is occupied by an acyl group such as a fatty acid and the sn-2 position remains unoccupied. The fatty acid may be one with anti-inflammatory properties.

Sn-1(3) monoacylglycerides and lipid absorption

Growing community of inventors

Servion, Switzerland

Frederic Destaillats